Health insurance is supposed to make medical care more accessible. Yet for many Americans living with diabetes, asthma, heart disease, arthritis, depression, or another chronic condition, a high-deductible health plan can feel like owning an umbrella that opens only after you are already soaked.
High-deductible health plans, commonly called HDHPs, often offer lower monthly premiums and access to tax-advantaged health savings accounts. Those advantages can work well for people who have enough savings and use relatively little medical care. Chronic illness changes the calculation, however. When someone needs recurring prescriptions, laboratory tests, specialist visits, therapy, or medical equipment, a large deductible can become a financial checkpoint placed directly in front of essential care.
The problem is not simply that medical services cost money. It is that chronic conditions require consistent management. Delaying one appointment or stretching one prescription may appear to save money today while increasing the likelihood of complications, emergency treatment, missed work, and higher expenses tomorrow.
What Is a High-Deductible Health Plan?
A deductible is the amount an enrollee generally pays for covered services before the health plan begins paying its share. Some services may be covered before the deductible is met, but the details vary by plan. Preventive services required under federal rules are generally covered without cost sharing when received from an in-network provider, although diagnostic follow-up and treatment are not necessarily free.
High-deductible plans are no longer a niche product. In 2025, 33% of workers with employer-sponsored coverage were enrolled in an HDHP with a savings option. The average general annual deductible for single coverage among workers with a deductible was $1,886, and 34% faced a deductible of at least $2,000. Workers at smaller companies faced an average deductible of $2,631, considerably more than the average at larger firms. Meanwhile, average Affordable Care Act Marketplace deductibles reached $3,786 in 2026 after increasing 37% from the previous year.
These figures matter because a deductible is not an abstract insurance term. It represents rent money, grocery money, child care money, or the emergency fund that was already expected to handle a broken transmission. For someone with a chronic illness, the deductible may effectively become an annual admission fee for accessing routine care.
Why Chronic Conditions Make the Deductible Problem Different
A healthy enrollee might go months without visiting a doctor. Someone managing a chronic condition often cannot. Diabetes may require glucose-monitoring supplies, medications, A1C tests, eye examinations, and kidney screening. Asthma may involve controller inhalers, pulmonary testing, and urgent treatment during flare-ups. Rheumatoid arthritis can require specialist appointments, laboratory monitoring, imaging, and expensive specialty drugs.
Chronic and mental health conditions account for the overwhelming majority of U.S. health care spending. These conditions frequently require long-term treatment rather than a single, neatly packaged medical event. The expenses arrive repeatedly, often before an enrollee has satisfied the deductible.
The Deductible Resets, but the Disease Does Not
Most deductibles reset at the beginning of each plan year. Blood pressure, autoimmune disease, and chronic pain do not receive the memo. A patient who finally reaches the deductible late in the year may briefly enjoy lower cost sharing, only to return to paying the full negotiated price in January.
This reset creates a predictable financial crunch. Patients may schedule more care near the end of the year after meeting their deductible, then postpone appointments early in the next year. Unfortunately, diseases rarely organize their complications around an insurance calendar.
Uncertainty Can Be a Barrier by Itself
Patients do not always know what a visit, test, or procedure will cost. A physician may recommend an MRI, but the final expense can depend on the facility, network status, billing codes, prior authorization, and whether a radiologist sends a separate bill. Even people who technically have enough money may delay care because they cannot confidently estimate the total.
The result is a peculiar form of medical shopping anxiety: “Do I need this test now, or can I wait?” That may be a reasonable question when buying a new refrigerator. It is much less charming when the subject is chest pain.
What the Research Says About Delayed Care
Research increasingly shows that high deductibles can affect when people seek care and whether they receive recommended treatment. A 2025 study involving hundreds of thousands of commercially insured adults found that employer-mandated enrollment in an HDHP was associated with delayed diabetes diagnosis. The estimated delay was approximately 1.7 months overall and 2.1 months among women. Newly diagnosed members also experienced relative increases in total and out-of-pocket medical costs surrounding the diagnosis.
Earlier research involving people with diabetes found delays of approximately 1.5 months before seeking care for major vascular symptoms, 1.9 months before receiving diagnostic testing, and 3.1 months before undergoing procedure-based treatment after switching to high-deductible coverage. Another study associated employer-forced HDHP enrollment with increased odds of potentially preventable acute diabetes complications.
The effects can appear in highly specific areas of disease management. Research has linked HDHP enrollment among people with diabetes to delayed diagnosis or treatment of retinopathy and vision loss. A 2025 longitudinal study of more than 343,000 adults with chronic illnesses also found that HDHP enrollment was associated with reduced receipt of guideline-recommended medical care.
Not every patient responds in the same way, and not every service declines after a deductible increase. Some studies find small or limited changes in routine monitoring. Nevertheless, the broader pattern is concerning: patients often reduce both low-value and high-value care because insurance designs do not hand them a tiny medical economist who whispers which services are safe to skip.
How High Deductibles Disrupt Chronic Disease Management
Patients Delay Office Visits
When a primary care or specialist appointment costs the full negotiated rate before the deductible, routine follow-up can begin to feel optional. Patients may wait until symptoms worsen, combine several concerns into one rushed visit, or rely on online advice instead of professional evaluation.
Delaying a routine visit may mean missing an opportunity to adjust medication, identify side effects, review laboratory results, or catch early signs of deterioration. A $180 visit avoided today can become a much more expensive urgent-care or emergency-department visit later.
Testing Becomes a Financial Decision
Laboratory tests and imaging are essential for many chronic conditions, but patients may decline them after learning that they are subject to the deductible. A screening service may be covered without cost sharing, while a follow-up test prompted by an abnormal result may be categorized as diagnostic and generate a bill.
This distinction makes sense in insurance manuals and considerably less sense to a patient who assumed “covered” meant “paid for.” Confusion about preventive versus diagnostic services can discourage people from completing the very follow-up care that makes screening valuable.
Prescription Adherence Suffers
Medication is one of the easiest expenses to quietly reduce. Patients may postpone refills, split pills, use a lower dose, switch to over-the-counter products, or take medication only when symptoms become noticeable. These strategies may be invisible to clinicians unless patients feel comfortable discussing financial stress.
National survey data show that cost-related medication nonadherence remains common. In 2021, 8.2% of adults ages 18 to 64 who used prescription medication reported not taking it as prescribed to reduce costs. More recent polling suggests that many Americans continue to delay filling prescriptions, skip doses, or substitute nonprescription products because of price.
Mental Health and Rehabilitation Care May Be Cut First
Psychotherapy, physical therapy, occupational therapy, and similar services commonly involve multiple visits. Even a moderate per-visit charge becomes substantial when repeated weekly. Patients may attend only a few sessions, space appointments farther apart, or stop once symptoms improve slightly rather than completing the recommended course.
This is a critical weakness of high-deductible coverage: the plan may technically cover a service while making sustained use financially unrealistic.
Who Is Most Vulnerable?
The burden of a high deductible depends not only on its dollar amount but also on the resources available to pay it. A $2,000 deductible may be manageable for a household with substantial savings. For a family living paycheck to paycheck, it can represent an impossible barrier.
Lower-income patients, people with several chronic conditions, families with frequent pediatric care, and individuals who require specialty medications face greater exposure. Workers at small firms may encounter higher deductibles, while employer contributions to HSAs and health reimbursement arrangements vary widely. In 2025, only a small share of workers in HSA-qualified HDHPs received an employer contribution large enough to equal the full deductible.
Health literacy and access to price information also matter. Choosing among formularies, networks, coinsurance rates, separate drug deductibles, and out-of-pocket maximums can be difficult even for experienced consumers. Add fatigue, pain, caregiving responsibilities, or limited English proficiency, and the phrase “consumer-directed health care” starts doing a lot of optimistic heavy lifting.
Are High-Deductible Plans Always a Bad Choice?
No. HDHPs can offer meaningful advantages. Premiums may be lower, HSA contributions can reduce taxable income, and unused HSA funds can roll over from year to year. Someone with strong savings, a generous employer contribution, and limited medical needs may spend less overall with an HDHP.
Enrollees also receive their insurer’s negotiated rates for covered in-network services, even before reaching the deductible. Many plans cover selected office visits or prescriptions before the general deductible, and federal rules protect qualifying in-network preventive services from cost sharing in most non-grandfathered plans.
The more important question is whether the plan fits the patient. A low premium does not automatically equal affordable coverage. People with chronic conditions should compare total annual costs, including premiums, expected medications, specialist visits, laboratory services, coinsurance, employer account contributions, and the out-of-pocket maximum.
Practical Ways Patients Can Reduce the Barrier
- Read the Summary of Benefits and Coverage. Identify which office visits, drugs, tests, and services are covered before the deductible.
- Check the drug formulary. Confirm the coverage tier, prior-authorization requirements, and whether a separate prescription deductible applies.
- Ask for an estimate before scheduled care. Request the insurer’s negotiated price and compare independent facilities when appropriate.
- Discuss costs directly with clinicians. Doctors may be able to prescribe a generic, recommend a lower-cost facility, reduce unnecessary testing, or arrange a longer prescription supply.
- Use HSA funds strategically. Automatic contributions can spread expenses across the year instead of forcing a financial scramble when care is needed.
- Explore assistance programs. Hospitals, community health centers, drug manufacturers, and nonprofit organizations may offer income-based support.
- Do not ignore urgent warning signs. New chest pain, severe shortness of breath, sudden weakness, confusion, or other emergency symptoms should not wait for a deductible calculation.
How Employers and Policymakers Can Improve Plan Design
A deductible does not have to treat every service as equally disposable. Value-based insurance design reduces or removes cost sharing for services that are especially important for preventing complications. Examples include insulin, blood pressure medication, statins, asthma controllers, glucose-monitoring supplies, and disease-specific laboratory testing.
Federal guidance has given HSA-eligible plans more flexibility to cover selected chronic-condition services before the deductible. Research from the Employee Benefit Research Institute found evidence that expanded pre-deductible coverage improved adherence in 2022, including a four-percentage-point increase in insulin use among eligible people with diabetes and a smaller increase in statin use among people with heart disease or diabetes.
Employers can also make plans more usable by contributing meaningful amounts to HSAs, depositing funds at the beginning of the year, offering fixed copays for chronic care, providing transparent price tools, and giving employees access to benefits counselors. A deductible may reduce unnecessary utilization, but a plan has missed the plot if it also discourages the care that prevents amputations, strokes, hospitalizations, or severe mental health episodes.
A Composite Experience: What Living With an HDHP Can Feel Like
Consider Maria, a fictional patient whose situation combines experiences commonly reported by people managing chronic illness. She is 46, works full time, and has type 2 diabetes and hypertension. Her employer offers two insurance choices. The traditional plan has a higher monthly premium, while the HDHP looks less expensive on payday and includes an HSA.
During open enrollment, Maria chooses the HDHP because the premium savings are immediate and visible. The deductible is less visible. It sits quietly in a benefits document, waiting for January like a financial jump scare.
Her first refill of the year is more expensive than expected because one medication is subject to the deductible. She pays it, but she postpones an appointment with her endocrinologist until the following month. Then her car needs repairs. The appointment moves again.
By spring, Maria notices that her blood sugar readings are higher. Her doctor orders laboratory tests and recommends a retinal examination. The annual physical itself is covered as preventive care, but the additional tests and follow-up services are not free. Maria calls the insurer, the laboratory, and the doctor’s office. Each gives her a slightly different estimate.
Nothing has been denied. Technically, everything is covered. Practically, Maria must spend several hundred dollars before the plan pays much of anything. She schedules the blood test but delays the eye examination because she has no vision symptoms. This feels logical. It is also precisely how silent complications can remain undetected.
Later, Maria develops numbness in one foot. She waits several weeks, hoping it will disappear. She is not careless and she does not misunderstand diabetes. She is making a household budget decision while balancing groceries, utilities, and a teenager who has somehow outgrown every pair of shoes at once.
When she finally sees her doctor, she needs additional testing and a medication adjustment. The combined bills push her closer to the deductible. Ironically, she can now afford care more easily because she has already spent so much. Insurance has begun helping at the exact moment her checking account has filed an emotional complaint.
Maria’s story illustrates why high-deductible plans can be especially difficult for chronic conditions. The barrier is not always a dramatic refusal of care. It appears through small delays: a refill postponed for five days, an appointment moved to next month, a test deferred until the next paycheck, or a therapy session canceled because several other bills arrived together.
Each decision may seem reasonable in isolation. Over time, however, the delays can weaken disease control and increase the risk of complications. The experience also carries an emotional cost. Patients may feel guilty for not following medical advice, embarrassed to mention money, or exhausted by repeatedly calling insurers and providers for prices that remain uncertain.
A better plan would not necessarily make every service free. It would distinguish between discretionary spending and high-value chronic care. Maria could still have an incentive to compare prices for nonurgent imaging while receiving affordable access to medications, monitoring, and follow-up services that keep her condition stable.
This distinction is central to smarter insurance design. Patients with chronic illnesses are not simply consuming more care because the price is low. They are managing diseases that require continuous attention. Asking them to pay thousands of dollars before receiving meaningful coverage may reduce short-term utilization, but the care being reduced is not always care the health system can afford to lose.
Conclusion
High-deductible health plans can lower premiums and provide valuable HSA benefits, but they may also create serious barriers for people who need ongoing medical care. Chronic conditions do not wait for a deductible to be met, and patients should not have to choose between maintaining their health and maintaining their household budget.
The evidence does not suggest that every HDHP produces poor outcomes or that patients should never select one. It does show that higher cost sharing can delay diagnosis, reduce recommended care, disrupt medication use, and place disproportionate pressure on people with limited financial resources.
The most promising solution is not simply more insurance. It is better-designed insurance: coverage that protects high-value medications, monitoring, and chronic disease services before the deductible while preserving reasonable incentives to avoid wasteful spending. After all, the goal of a health plan should be to help people manage illness before it becomes a crisisnot to offer excellent coverage immediately after the crisis has emptied their savings.
